PennyStockPayCheck.com Rss

Featured Posts

Chase Bank Limits Cash Withdrawals, Bans International... Before you read this report, remember to sign up to http://pennystockpaycheck.com for 100% free stock alerts Chase Bank has moved to limit cash withdrawals while banning business customers from sending...

Read more

Richemont chairman Johann Rupert to take 'grey gap... Billionaire 62-year-old to take 12 months off from Cartier and Montblanc luxury goods groupRichemont's chairman and founder Johann Rupert is to take a year off from September, leaving management of the...

Read more

Cambodia: aftermath of fatal shoe factory collapse... Workers clear rubble following the collapse of a shoe factory in Kampong Speu, Cambodia, on Thursday

Read more

Spate of recent shock departures by 50-something CEOs While the rising financial rewards of running a modern multinational have been well publicised, executive recruiters say the pressures of the job have also been ratcheted upOn approaching his 60th birthday...

Read more

UK Uncut loses legal challenge over Goldman Sachs tax... While judge agreed the deal was 'not a glorious episode in the history of the Revenue', he ruled it was not unlawfulCampaign group UK Uncut Legal Action has lost its high court challenge over the legality...

Read more

Sheila Bair: "I’m sure Vikram still blames me"

Category : Business

Fortune columnist and former head of the FDIC Sheila Bair discusses the ouster of Citi CEO Vikram Pandit.

Follow this link: Sheila Bair: "I’m sure Vikram still blames me"

Post to Twitter

The Next Big Thing In Biotech: ASCO Conference

Category : Business

Senior columnist Adam Feuerstein says the ASCO Cancer Conference is the next big thing in biotech.

See the rest here: The Next Big Thing In Biotech: ASCO Conference

Post to Twitter

The Next Big Thing in Biotech: Pfizer

Category : Stocks

Senior columnist Adam Feuerstein says Pfizer is the next big thing in biotech.

Go here to see the original: The Next Big Thing in Biotech: Pfizer

Post to Twitter

The Next Big Thing in Biotech: M&A

Category : Business, Stocks

Senior columnist Adam Feuerstein says M&A is the next big thing in biotech.

Read the original: The Next Big Thing in Biotech: M&A

Post to Twitter

AUDIO: ‘Pay your taxes before charity’

Category : World News

As the debate over whether to limit tax relief on charitable donations rumbles on, Polly Toynbee, writer, commentator and Guardian columnist, and John Low, chief executive of Charities Aid Foundation, debate the arguments in favour of the policy.

Read the original here: AUDIO: ‘Pay your taxes before charity’

Post to Twitter

The Next Big Thing in Biotech: Alexza

Category : Stocks

Adam Feuerstein, senior columnist for TheStreet, explains why Alexza Pharmaceuticals is the next big thing in biotech.

See more here: The Next Big Thing in Biotech: Alexza

Post to Twitter

David Miliband, Jeffrey Sachs and Ngaire Woods: watch the debate in full – video

Category : Business

Are we facing a crisis of democracy? Guardian columnist Jonathan Freedland chairs a debate at the Guardian Open Weekend between David Miliband, Jeffrey Sachs and Ngaire Woods

alt : http://cdn.theguardian.tv/brightcove/2012/4/12/120411democracylong-16×9.mp4http://cdn.theguardian.tv/brightcove/2012/4/12/120411democracylong-16×9.mp4< ![endif]-->

Read more here: David Miliband, Jeffrey Sachs and Ngaire Woods: watch the debate in full – video

Post to Twitter

The Next Big Thing in Biotech: Vivus

Category : Business, Stocks

Senior columnist Adam Feuerstein explains why Vivus is the next big thing in biotech.

See the original post: The Next Big Thing in Biotech: Vivus

Post to Twitter

The Next Big Thing in Biotech: FDA Decisions

Category : Business

Senior columnist Adam Feuerstein explains the importance of three FDA drug approval decisions.

Read the original here: The Next Big Thing in Biotech: FDA Decisions

Post to Twitter

Did Pierre Poutine’s robocalls go beyond Guelph?

Category : World News

This week on The House, guest-host Alison Crawford brings you the latest developments in the robocall affair with CBC Senior Political Correspondent Terry Milewski and John Ivison, political columnist for The National Post.

Here is the original post: Did Pierre Poutine’s robocalls go beyond Guelph?

Post to Twitter